Sequoia Financial Advisors LLC Has $1.16 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Sequoia Financial Advisors LLC increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 16.8% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,858 shares of the company’s stock after purchasing an additional 412 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in HCA Healthcare were worth $1,162,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. Terra Nova Asset Management LLC boosted its stake in HCA Healthcare by 0.3% in the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after purchasing an additional 26 shares during the period. Massmutual Trust Co. FSB ADV grew its holdings in shares of HCA Healthcare by 7.4% during the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after buying an additional 29 shares in the last quarter. Brookstone Capital Management boosted its position in HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after acquiring an additional 30 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares during the last quarter. Finally, Lake Street Advisors Group LLC grew its position in HCA Healthcare by 1.3% in the second quarter. Lake Street Advisors Group LLC now owns 2,732 shares of the company’s stock valued at $878,000 after purchasing an additional 35 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Leerink Partners raised their price objective on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Barclays upped their price objective on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 24th. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. Finally, Morgan Stanley started coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Five analysts have rated the stock with a hold rating, twelve have issued a buy rating and four have given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $377.17.

HCA Healthcare Stock Down 8.8 %

Shares of HCA opened at $363.75 on Friday. The stock has a market capitalization of $95.27 billion, a PE ratio of 18.01, a P/E/G ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a 12 month low of $220.55 and a 12 month high of $417.14. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The firm’s 50 day moving average is $395.26 and its 200-day moving average is $352.63.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter last year, the business earned $4.29 earnings per share. HCA Healthcare’s revenue was up 10.3% on a year-over-year basis. Equities research analysts forecast that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.73%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Insider Activity

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,345 shares of company stock worth $5,747,945. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.